相关实验视频
Updated: Jul 21, 2025

04:23
Application of Hemostatic Devices in Laparoscopic Hepatectomy
Published on: April 19, 2022
2.3K
在主要泌尿外科手术中使用局部静血剂的趋势,成本和预测因素
Camilo Arenas-Gallo1, Patrick Lewicki2, Megan Prunty1
1Department of Urology, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.
Urology practice
|July 27, 2023
概括
局部静血剂在泌尿外科手术中越来越多地使用. 他们的成本是最小的,占住院费用的不到1.6%,使用量因患者和医院因素而异.
科学领域:
- 泌尿外科手术 泌尿外科手术
- 外科手术静血 静血是什么
- 医疗保健分析 医疗保健分析
背景情况:
- 在此之前,血液静止剂使用的全国趋势和主要泌尿外科手术的成本是未知的.
- 了解这些趋势对于优化外科实践和资源配置至关重要.
研究的目的:
- 分析2000 - 2020年主要泌尿外科手术中局部静血剂的全国使用和成本趋势.
- 根据手术方法,患者和医院的特征来确定血液静止剂使用的预测因素.
主要方法:
- 来自Premier医疗保健数据库 (2000-2020年) 的385,261个患者遭遇的分析.
- 在开放式和微创性泌尿外科手术中对局部静血剂使用模式的描述性分析.
- 多变量回归分析以确定血液静止剂使用的预测因素.
主要成果:
- 到2020年,血液静止剂的使用在各种主要泌尿外科手术中增加,包括前列腺切除和切除.
- 使用的预测因素包括患者人口统计学,种族,手术方法,保险,位置和外科医生的数量.
- 血液静止剂的成本占住院总成本的不到1.6%.
结论:
- 在主要的泌尿外科手术中,血液静止剂的使用在过去二十年中显著增长.
- 血液静止剂的成本贡献是最小的,并且在开放式和最小侵入性方法中是一致的.
- 患者,外科医生和医院因素显著影响静血剂的使用.
相关概念视频
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Anticoagulant Drugs: Low-Molecular-Weight Heparins
755
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
755
Venous Thrombosis IV: Nursing Management
14
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
14
Introduction to Hemostasis
8.3K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.3K
Aneurysm IV: Nursing Management
8
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
8
Extrinsic and Intrinsic Pathways of Hemostasis
8.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.3K

